ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0118

Physical Performance Among Individuals with Systemic Lupus Erythematosus in a Diverse Population-Based Cohort

Courtney Hoge1, C. Barrett Bowling2, Charmayne Dunlop-Thomas1, Bradley Pearce1, S. Sam Lim1, Cristina Drenkard1 and Laura Plantinga1, 1Emory University, Atlanta, GA, 2Duke University, Durham, NC

Meeting: ACR Convergence 2023

Keywords: Epidemiology, physical function, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0117–0144) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Physical performance is often not measured in clinical settings, despite its association with increased risk of disability, loss of independence, and mortality. Here, we sought to examine the prevalence and correlates of poor physical performance among individuals with systemic lupus erythematosus (SLE) who were recruited from a primarily Black, population-based cohort in Atlanta.

Methods: Participants were recruited for an ancillary study from the ongoing, population-based Georgians Organized Against Lupus (GOAL) cohort of individuals with SLE. Those who had complete Short Physical Performance Battery [SPPB: score range, 0-12; intermediate-low (< 10) vs. high (≥10)] data from either an in-person or a remote study visit (10/8/19-5/12/22) were included. Demographic, clinical, and psychosocial variables were summarized, and the associations [adjusted odds ratios (aOR)] of intermediate-low vs. high physical performance with these characteristics were estimated via multivariable logistic regression.

Results: Among 446 participants (mean age 46.2, 91.7% female, and 82.5% Black), more than half (59.6%) had poor (intermediate-low) overall physical performance (Figure 1). Only 7% of the cohort received the maximum score on the lower body strength task, as opposed to 90% and 76% receiving the maximum scores on balance and gait speed tasks, respectively (Figure 2). Current employment status and higher cognitive functioning were associated with 31% and 43% lower odds of intermediate-low physical performance (Table 1). Higher body mass index, disease activity, and disease burden were associated with 25%, 59%, and 38% higher odds of poorer performance, as were higher depressive symptom and perceived stress scores and lower educational attainment.

Conclusion: In our diverse cohort of individuals with SLE, we found a high burden of low to intermediate physical performance and identified SLE- and non-SLE-related factors associated with poorer performance. Clinicians may use these results to identify patients who are most at risk for suboptimal physical performance and intervene to maintain or improve performance levels, which could delay or prevent associated poor outcomes and help ensure continued independence.

Supporting image 1

Figure 1. Short Physical Performance Battery scores (range 0_12, higher scores indicating higher levels of physical performance) among study participants, overall and by participant demographics.

Supporting image 2

Figure 2. Short Physical Performance Battery subscores (range 0_4, 0=inability to perform task, 4=highest level of performance) for balance, gait speed, and lower body strength (chair stands) among study participants.

Supporting image 3

Table 1. Associations of intermediate or low (<10) vs. high (10_12) physical performance scores with participant characteristics.


Disclosures: C. Hoge: None; C. Bowling: None; C. Dunlop-Thomas: None; B. Pearce: None; S. Lim: None; C. Drenkard: None; L. Plantinga: None.

To cite this abstract in AMA style:

Hoge C, Bowling C, Dunlop-Thomas C, Pearce B, Lim S, Drenkard C, Plantinga L. Physical Performance Among Individuals with Systemic Lupus Erythematosus in a Diverse Population-Based Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/physical-performance-among-individuals-with-systemic-lupus-erythematosus-in-a-diverse-population-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-performance-among-individuals-with-systemic-lupus-erythematosus-in-a-diverse-population-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology